EU faces world's fastest growing HIV epidemic

Marshall, Sarah Jane
April 2004
Bulletin of the World Health Organization;Apr2004, Vol. 82 Issue 4, p310
Academic Journal
Focuses on the increasing growth rates of HIV infection in European Union countries. Impact of HIV/AIDS epidemic with economic and social development; Percentage of HIV-infected people receiving antiretroviral treatment; People with high risk of contracting HIV.


Related Articles

  • THE EUROSIDA STUDY: REGIONAL DIFFERENCES IN THE HIV-1 EPIDEMIC AND TREATMENT RESPONSE TO ANTIRETROVIRAL THERAPY AMONG HIV-INFECTED PATIENTS ACROSS EUROPE -- A REVIEW OF PUBLISHED RESULTS. Podlekareva, Daria; Bannister, Wendy; Mocroft, Amanda; Abrosimova, Ludmila; Karpov, Igor; Lundgren, Jens D.; Kirk, Ole // Central European Journal of Public Health;2008, Vol. 16 Issue 3, p99 

    EuroSIDA is a pan-European observational study that follows 14,265 HIV-infected patients from 31 European countries, Israel and Argentina, of which 2,560 are patients from eastern Europe (EE). The study group has performed several analyses addressing regional differences in the HIV-epidemic...

  • Cure call to mark AIDS anniversary. KATABIRA, ELLY // Nursing Review (1175-2904);Jul2011, Vol. 12 Issue 3, p18 

    The author discusses the need to find a cure for people living with HIV. According to the author, there are compelling evidence that HIV treatment is also HIV prevention and that expanding antiretroviral therapy has preventative benefits for the entire community. As such, the International AIDS...

  • Delayed Progression to Death and to AIDS in a Hong Kong Cohort of Patients with Advanced HIV Type 1 Disease During the Era of Highly Active Antiretroviral Therapy. Ka Hing Wong; Kenny Chi Wai Chan; Shui Shan Lee // Clinical Infectious Diseases;9/15/2004, Vol. 39 Issue 6, p853 

    Background. The magnitude of the impact of highly active antiretroviral therapy (HAART) since its introduction in non-Western countries is not entirely clear. We studied disease progression among adult patients with advanced human immunodeficiency virus type 1 (HIV-1) infection in the pre-HAART...

  • Mortality and Morbidity of HIV Infected Patients Receiving HAART: A Cohort Study. Panos, George; Samonis, George; Alexiou, Vangelis G.; Kavarnou, Garyfallia A.; Charatsis, Gerasimos; Falagas, Matthew E. // Current HIV Research;May2008, Vol. 6 Issue 3, p257 

    HAART has substantially decreased mortality and morbidity among HIV-infected patients. We retrospectively analyzed morbidity and mortality in a cohort of HIV-infected adult patients with prolonged and frequent follow up (1987-2006). The study was divided in pre-HAART and HAART period for...

  • Modelling T4 cell count as a marker of HIV progression in the absence of any defense mechanism. Yadavalli, Venkata S. Sarma; Labeodan, Moremi Morire OreOluwapo; Udayabaskaran, Swaminathan; Forche, N. // Orion;2010, Vol. 26 Issue 2, p113 

    The T4 cell count, which is considered one of the markers of disease progression in an HIV infected individual, is modelled in this paper. The World Health Organisation has recently advocated that countries encourage HIV infected individuals to commence antiretroviral treatments once their T4...

  • HIV-Induced T-Cell Activation/Exhaustion in Rectal Mucosa Is Controlled Only Partially by Antiretroviral Treatment. Rueda, Cesar Mauricio; Velilla, Paula Andrea; Chougnet, Claire A.; Montoya, Carlos Julio; Rugeles, Maria Teresa // PLoS ONE;Jan2012, Vol. 7 Issue 1, p1 

    Peripheral blood T-cells from untreated HIV-1-infected patients exhibit reduced immune responses, usually associated with a hyperactivated/exhausted phenotype compared to HAART treated patients. However, it is not clear whether HAART ameliorates this altered phenotype of T-cells in the...

  • Antiretroviral prescribing delayed among certain patients.  // PharmacoEconomics & Outcomes News;4/24/2004, Issue 451, p7 

    Discusses a study conducted by researchers in the U.S. in April 2004, which revealed the delay of antiretroviral therapy for nonadherent HIV-infected patients caused by physicians who follow guidelines on antiretroviral treatment. Number of patients with HIV infections that were evaluated;...

  • Prevalence of intestinal parasites in relation to CD4 counts and anaemia among HIV-infected patients in Benin City, Edo State, Nigeria. Akinbo, Frederick O.; Okaka, Christopher E.; Omoregie, Richard // Tanzania Journal of Health Research;Feb2011, Vol. 13 Issue 1, p10 

    Parasitic infections continue to take their toll on HIV positive patients by influencing the blood qualitatively and quantitatively. The objective of this study was to determine the prevalence of intestinal parasitic infections in relation to anaemia and CD4 counts among HIV-infected patients in...

  • Partner protection. Coghlan, Andy // New Scientist;4/28/2012, Vol. 214 Issue 2862, p4 

    The article discusses a recommendation from the World Health Organization (WHO) to immediately give any person with HIV, whose partner is not infected, antiretroviral drugs to prevent HIV transmission.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics